Alpha Tau Medical Ltd (DRTS) is a Healthcare · Biotechnology company listed on NASDAQ. Price $15.24 (-1.61%), Market cap $0.75B, 52-week low–high $2.59 ~ $8.54.
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.
Financial statements, price targets, institutional (13F) holdings and related news for Alpha Tau Medical Ltd are updated in real time on BlackAll Trade.
Alpha Tau Medical Ltd trades at $15.24 (-1.61%). Real-time quotes and charts are available on BlackAll Trade.
Alpha Tau Medical Ltd has a market cap of about $0.75B.
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the t